The regulatory role of glycolysis-related proteins, such as fructose-1,6-bisphosphatase (FBP1), which encodes a rate-limiting gluconeogenic enzyme, has been reported to play a role in tumor suppression in many cancers (62). This evidence concerns the gene FBP1 and neoplasm.